Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx
Open Access
- 23 November 2010
- journal article
- clinical trial
- Published by Wiley in International Journal of Cancer
- Vol. 129 (6) , 1404-1409
Abstract
In patients with early head and neck squamous cell carcinoma (HNSCC), occult lymph node metastasis is difficult to predict by clinical or pathological parameters. However, such parameters are necessary to select patients either for elective neck dissection or the sentinel lymph node (SLN) procedure. The membrane glycoprotein podoplanin is normally expressed in lymphatic endothelial cells. Recently, expression of podoplanin by cancer cells was demonstrated to promote tumor cell motility and tumor lymphangiogenesisin vitro. The value of cancer cell‐expressed podoplanin was to be determined as a predictive marker for SLN metastasis in early HNSCC of the oral cavity and oropharynx. One hundred twenty patients with HNSCC of the oral cavity and oropharynx undergoing a SLN biopsy were enrolled in this prospective clinical trial of SLN biopsy. Cancer cell‐expressed podoplanin was determined by immunohistochemistry using tissue microarrays. Podoplanin expression was quantified by the intensity reactivity score and categorized into expression and nonexpression. SLN examination revealed occult metastasis in 45 patients (37.5%). Twenty‐nine of 120 (24.2%) primary HNSCC showed podoplanin expression. Podoplanin expression correlated significantly with SLN metastasis (p= 0.029) and remained a significant predictor for lymph node status even after controlling for tumor stage (p= 0.028). As a predictive marker for SLN metastasis, however, podoplanin expression reached a sensitivity of a mere 36% and a specificity of 83%. Podoplanin expression is associated with metastasis to lymph nodesin vivo.Podoplanin immunohistochemistry in early HNSCC of the oral cavity and oropharynx may help to select patients for the SLN procedure and to identify patients with increased risk for presence of occult lymph node metastasis in the neck.Keywords
This publication has 25 references indexed in Scilit:
- Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skinBlood, 2010
- Tumor Lymphangiogenesis and Metastasis to Lymph Nodes Induced by Cancer Cell Expression of PodoplaninThe American Journal of Pathology, 2010
- Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2Retrovirology, 2010
- Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlationsVirchows Archiv, 2010
- Value of p63 and podoplanin (D2‐40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 casesJournal of Cutaneous Pathology, 2010
- Podoplanin expression in the development and progression of laryngeal squamous cell carcinomasMolecular Cancer, 2010
- Evaluation of Clinical and Histomorphological Parameters as Potential Predictors of Occult Metastases in Sentinel Lymph Nodes of Early Squamous Cell Carcinoma of the Oral CavityAnnals of Surgical Oncology, 2009
- The Platelet Aggregation-Inducing Factor Aggrus/Podoplanin Promotes Pulmonary MetastasisThe American Journal of Pathology, 2007
- The potential role of podoplanin in tumour invasionBritish Journal of Cancer, 2006
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998